{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T03:24:01Z","timestamp":1794885841278,"version":"4.9.1"},"reference-count":49,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:00:00Z","timestamp":1619568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014139","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer","doi-asserted-by":"publisher","award":["CB16\/12\/00390"],"award-info":[{"award-number":["CB16\/12\/00390"]}],"id":[{"id":"10.13039\/501100014139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/00560"],"award-info":[{"award-number":["PI19\/00560"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>The presence of tumor-infiltrating lymphocytes (TIL) in the tumor microenvironment has been demonstrated to be of prognostic value in various cancers. In this systematic review and meta-analysis, we investigated the prognostic value of TIL in laryngeal squamous cell carcinoma (LSCC). We performed a systematic search in PubMed for publications that investigated the prognostic value of TIL in LSCC. A meta-analysis was performed including all studies assessing the association between TIL counts in hematoxylin-eosin (HE)-stained sections, for CD8+ and\/or CD3+\/CD4+ TIL and overall survival (OS) or disease-free survival (DFS). The pooled meta-analysis showed a favorable prognostic role for stromal TIL in HE sections for OS (HR 0.57, 95% CI 0.36\u20130.91, p = 0.02), and for DFS (HR 0.56, 95% CI 0.34\u20130.94, p = 0.03). High CD8+ TIL were associated with a prolonged OS (HR 0.62, 95% CI 0.4\u20130.97, p = 0.04) and DFS (HR 0.73, 95% CI 0.34\u20130.94, p = 0.002). High CD3+\/CD4+ TIL demonstrated improved OS (HR 0.32, 95% CI 0.16\u20130.9, p = 0.03) and DFS (HR 0.23, 95% CI 0.10\u20130.53, p = 0.0005). This meta-analysis confirmed the favorable prognostic significance of TIL in LSCC. High stromal TIL evaluated in HE sections and intra-tumoral and stromal CD3+, CD4+ and\/or CD8+ TIL might predict a better clinical outcome.<\/jats:p>","DOI":"10.3390\/biomedicines9050486","type":"journal-article","created":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T22:29:07Z","timestamp":1619648947000},"page":"486","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Tumor-Infiltrating Lymphocytes in the Tumor Microenvironment of Laryngeal Squamous Cell Carcinoma: Systematic Review and Meta-Analysis"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3063-0890","authenticated-orcid":false,"given":"Juan P.","family":"Rodrigo","sequence":"first","affiliation":[{"name":"Department of Otolaryngology, Hospital Universitario Central de Asturias-Instituto de Salud del Principado de Asturias (ISPA), 33011 Oviedo, Spain"},{"name":"IUOPA-University of Oviedo, 33006 Oviedo, Spain"},{"name":"CIBERONC, Instituto de Salud Carlos III, 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0343-0041","authenticated-orcid":false,"given":"Mario","family":"S\u00e1nchez-Canteli","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, Hospital Universitario Central de Asturias-Instituto de Salud del Principado de Asturias (ISPA), 33011 Oviedo, Spain"},{"name":"IUOPA-University of Oviedo, 33006 Oviedo, Spain"},{"name":"CIBERONC, Instituto de Salud Carlos III, 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7019-9746","authenticated-orcid":false,"given":"Fernando","family":"L\u00f3pez","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, Hospital Universitario Central de Asturias-Instituto de Salud del Principado de Asturias (ISPA), 33011 Oviedo, Spain"},{"name":"IUOPA-University of Oviedo, 33006 Oviedo, Spain"},{"name":"CIBERONC, Instituto de Salud Carlos III, 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory T.","family":"Wolf","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology-Head and Neck Surgery, University of Michigan Health System, Ann Arbor, MI 48109, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Hern\u00e1ndez-Prera","sequence":"additional","affiliation":[{"name":"Department of Pathology, Moffitt Cancer Center, Tampa, FL 33612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle D.","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan M.","family":"Willems","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1332-5838","authenticated-orcid":false,"given":"Alessandro","family":"Franchi","sequence":"additional","affiliation":[{"name":"Department of Translational Research, School of Medicine, University of Pisa, 56126 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Coca-Pelaz","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, Hospital Universitario Central de Asturias-Instituto de Salud del Principado de Asturias (ISPA), 33011 Oviedo, Spain"},{"name":"IUOPA-University of Oviedo, 33006 Oviedo, Spain"},{"name":"CIBERONC, Instituto de Salud Carlos III, 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfio","family":"Ferlito","sequence":"additional","affiliation":[{"name":"Coordinator of the International Head and Neck Scientific Group, 35125 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,4,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","article-title":"Head and neck squamous cell carcinoma","volume":"6","author":"Johnson","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1158\/1078-0432.CCR-18-1851","article-title":"The Immunoscore: Colon Cancer and Beyond","volume":"26","author":"Angell","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1200\/JCO.2015.61.1509","article-title":"Immunology and Immunotherapy of Head and Neck Cancer","volume":"33","author":"Ferris","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/bjc.2013.746","article-title":"Tumour-infiltrating lymphocytes in the risk stratification of squamous cell carcinoma of the head and neck","volume":"110","author":"Jones","year":"2014","journal-title":"Br. J. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.4287","article-title":"Towards the introduction of the \u2018Immunoscore\u2019 in the classification of malignant tumours","volume":"232","author":"Galon","year":"2014","journal-title":"J. Pathol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/bjc.2011.189","article-title":"The prognostic influence of tumour-infiltrating lymphocytes in cancer: A systematic review with meta-analysis","volume":"105","author":"Gooden","year":"2011","journal-title":"Br. J. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-5876-10-1","article-title":"The immune score as a new possible approach for the classification of cancer","volume":"10","author":"Galon","year":"2012","journal-title":"J. Transl. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1001\/jamaoto.2019.2427","article-title":"Prognostic Value of Tumor-Infiltrating Lymphocytes in Head and Neck Squamous Cell Carcinoma","volume":"145","author":"Spector","year":"2019","journal-title":"JAMA Otolaryngol. Neck Surg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e1356148","DOI":"10.1080\/2162402X.2017.1356148","article-title":"The prognostic role of tumor infiltrating T-lymphocytes in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis","volume":"6","author":"Ooft","year":"2017","journal-title":"OncoImmunology"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Borsetto, D., Tomasoni, M., Payne, K., Polesel, J., Deganello, A., Bossi, P., Tysome, J., Masterson, L., Tirelli, G., and Tofanelli, M. (2021). Prognostic Significance of CD4+ and CD8+ Tumor-Infiltrating Lymphocytes in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis. Cancers, 13.","DOI":"10.3390\/cancers13040781"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/hed.24406","article-title":"Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma","volume":"38","author":"Nguyen","year":"2016","journal-title":"Head Neck"},{"key":"ref_13","first-page":"354","article-title":"TILs in Head and Neck Cancer: Ready for Clinical Implementation and Why (Not)?","volume":"11","author":"Vermassen","year":"2016","journal-title":"Head Neck Pathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: Elaboration and explanation","volume":"349","author":"Shamseer","year":"2015","journal-title":"BMJ Br. Med. J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"19310","DOI":"10.18632\/oncotarget.14242","article-title":"Prognostic impact of immune microenvironment in laryngeal and pharyngeal squamous cell carcinoma: Immune cell subtypes, immuno-suppressive pathways and clinicopathologic characteristics","volume":"8","author":"Karpathiou","year":"2016","journal-title":"Oncotarget"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1158\/1078-0432.CCR-05-1886","article-title":"Prognostic Value of Tumor-Infiltrating CD4+ T-Cell Subpopulations in Head and Neck Cancers","volume":"12","author":"Badoual","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/bjc.2013.640","article-title":"Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer","volume":"110","author":"Balermpas","year":"2013","journal-title":"Br. J. Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3389\/fonc.2018.00604","article-title":"PD-1\/PD-L1 Axis, Rather Than High-Mobility Group Alarmins or CD8+ Tumor-Infiltrating Lymphocytes, Is Associated With Survival in Head and Neck Squamous Cell Carcinoma Patients Who Received Surgical Resection","volume":"8","author":"Yang","year":"2018","journal-title":"Front. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s12032-018-1241-1","article-title":"Characteristics and impact of programmed death-ligand 1 expression, CD8+ tumor-infiltrating lymphocytes, and p16 status in head and neck squamous cell carcinoma","volume":"36","author":"Ngamphaiboon","year":"2019","journal-title":"Med. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00262-020-02481-3","article-title":"Digital pathology-aided assessment of tumor-infiltrating T lymphocytes in advanced stage, HPV-negative head and neck tumors","volume":"69","author":"Brakenhoff","year":"2020","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.humpath.2018.07.012","article-title":"Prognostic and predictive values of immune infiltrate in patients with head and neck squamous cell carcinoma","volume":"82","author":"Zhang","year":"2018","journal-title":"Hum. Pathol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"104836","DOI":"10.1016\/j.oraloncology.2020.104836","article-title":"Prognostic role of programmed death ligand 1 (PD-L1) and the immune microenvironment in laryngeal carcinoma","volume":"108","author":"Alessandrini","year":"2020","journal-title":"Oral Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1007\/s12253-018-0501-x","article-title":"Expression of Programmed Death-Ligand 1 in Laryngeal Carcinoma and its Effects on Immune Cell Subgroup Infiltration","volume":"25","author":"Yu","year":"2018","journal-title":"Pathol. Oncol. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"826","DOI":"10.3109\/00016489.2016.1164341","article-title":"The ratio of CD4\/CD8 T-cells in human papillomavirus-positive laryngeal squamous cell carcinoma accounts for improved outcome","volume":"136","author":"Zhang","year":"2016","journal-title":"Acta Oto-Laryngol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/carcin\/bgaa058","article-title":"IL-23R in laryngeal cancer: A cancer immunoediting process that facilitates tumor cell proliferation and results in cisplatin resistance","volume":"42","author":"Tao","year":"2021","journal-title":"Carcinogenesis"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"153120","DOI":"10.1016\/j.prp.2020.153120","article-title":"Postoperative radiotherapy for laryngeal cancer. The prognostic role of programmed death-ligand 1: An immune microenvironment-based cluster analysis","volume":"216","author":"Franz","year":"2020","journal-title":"Pathol. Res. Pract."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s004050050169","article-title":"Immunohistochemical analysis of lymphocytic infiltration in the tumor microenvironment in patients operated on for laryngeal cancer","volume":"256","author":"Gabriel","year":"1999","journal-title":"Eur. Arch. Oto-Rhino-Laryngol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1097\/PAI.0000000000000590","article-title":"Expression of PD-L1 on Immune Cells Shows Better Prognosis in Laryngeal, Oropharygeal, and Hypopharyngeal Cancer","volume":"26","author":"Birtalan","year":"2018","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1080\/0284186X.2018.1445287","article-title":"Immune cell infiltration in head and neck squamous cell carcinoma and patient outcome: A retrospective study","volume":"57","author":"Schneider","year":"2018","journal-title":"Acta Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1002\/hed.26416","article-title":"Predictive value of CD8 \/ FOXP3 ratio combined with PD-L1 expression for radiosensitivity in patients with squamous cell carcinoma of the larynx receiving definitive radiation therapy","volume":"42","author":"Ono","year":"2020","journal-title":"Head Neck"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.oraloncology.2017.10.006","article-title":"A high ratio of IL-12R\u03b22-positive tumor-infiltrating lymphocytes indicates favorable prognosis in laryngeal cancer","volume":"74","author":"Tao","year":"2017","journal-title":"Oral Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3892\/or.2014.3553","article-title":"Functionally distinct subsets of CD4+ regulatory T cells in patients with laryngeal squamous cell carcinoma are indicative of immune deregulation and disease progression","volume":"33","author":"Sun","year":"2014","journal-title":"Oncol. Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1158\/1078-0432.CCR-15-1543","article-title":"Evaluation of PD-L1 Expression and Associated Tumor-Infiltrating Lymphocytes in Laryngeal Squamous Cell Carcinoma","volume":"22","author":"Vassilakopoulou","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"7177","DOI":"10.2147\/OTT.S113307","article-title":"The prognostic value of systemic and local inflammation in patients with laryngeal squamous cell carcinoma","volume":"9","author":"Wang","year":"2016","journal-title":"OncoTargets Ther."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.oraloncology.2017.12.003","article-title":"Proportion of CD4 and CD8 tumor infiltrating lymphocytes predicts survival in persistent\/recurrent laryngeal squamous cell carcinoma","volume":"77","author":"Hoesli","year":"2018","journal-title":"Oral Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00262-018-2256-3","article-title":"Analysis of tumor-infiltrating CD103 resident memory T-cell content in recurrent laryngeal squamous cell carcinoma","volume":"68","author":"Mann","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/s00432-019-02936-w","article-title":"Assessment of tumor-associated immune cells in laryngeal squamous cell carcinoma","volume":"145","author":"Zhou","year":"2019","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s12105-019-01101-6","article-title":"Tumor Infiltrating Lymphocytes and CD8+ T Cell Subsets as Prognostic Markers in Patients with Surgically Treated Laryngeal Squamous Cell Carcinoma","volume":"14","author":"Chatzopoulos","year":"2020","journal-title":"Head Neck Pathol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1007\/s00262-020-02604-w","article-title":"PD-L1 expression correlates with tumor-infiltrating lymphocytes and better prognosis in patients with HPV-negative head and neck squamous cell carcinomas","volume":"69","author":"Allonca","year":"2020","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-73747-0","article-title":"A role for the immune system in advanced laryngeal cancer","volume":"10","author":"Tagliabue","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Zhang, D., Tang, D., Heng, Y., Zhu, X., Zhou, L., Tao, L., and Lu, L. (2020). Prognostic Impact of Tumor-Infiltrating Lymphocytes in Laryngeal Squamous Cell Carcinoma Patients. Laryngoscope.","DOI":"10.1002\/lary.29196"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"151657","DOI":"10.1016\/j.anndiagpath.2020.151657","article-title":"Prognostic impact of neutrophils-to-lymphocytes ratio (NLR), PD-L1 expression, and tumor immune microenvironment in laryngeal cancer","volume":"50","author":"Franz","year":"2021","journal-title":"Ann. Diagn. Pathol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/00016487609119973","article-title":"Morphological Observations of Immunobiology of Laryngeal Cancer: Evaluation of the Defensive Activity of Immunocompetent Cells present In Tumour Stroma","volume":"81","author":"Sala","year":"1976","journal-title":"Acta Oto-Laryngol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.oraloncology.2018.10.005","article-title":"Utility of CD8 score by automated quantitative image analysis in head and neck squamous cell carcinoma","volume":"86","author":"Hartman","year":"2018","journal-title":"Oral Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(18)30789-X","article-title":"International validation of the consensus Immunoscore for the classification of colon cancer: A prognostic and accuracy study","volume":"391","author":"Mlecnik","year":"2018","journal-title":"Lancet"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/PAP.0000000000000162","article-title":"Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research","volume":"24","author":"Hendry","year":"2017","journal-title":"Adv. Anat. Pathol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/PAP.0000000000000161","article-title":"Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non\u2013Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors","volume":"24","author":"Hendry","year":"2017","journal-title":"Adv. Anat. Pathol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/00016489.2020.1720284","article-title":"Overall assessment of tumor-infiltrating lymphocytes in head and neck squamous cell carcinoma: Time to take notice","volume":"140","author":"Almangush","year":"2020","journal-title":"Acta Oto-Laryngol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.ccell.2018.11.003","article-title":"The Link between the Multiverse of Immune Microenvironments in Metastases and the Survival of Colorectal Cancer Patients","volume":"34","author":"Eynde","year":"2018","journal-title":"Cancer Cell"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/5\/486\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:54:52Z","timestamp":1760162092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/5\/486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,28]]},"references-count":49,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,5]]}},"alternative-id":["biomedicines9050486"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines9050486","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,28]]}}}